Offer - Urjas Oil for just ₹ 1 X
Lipicure CV 10/75 Capsule is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
13 - 18 years (Adolescent) |
|
Is the use of Lipicure CV 10/75 Capsule safe for pregnant women?
Lipicure CV can have harmful effects in pregnant women. If you experience any discomfort after using Lipicure CV, then discontinue the use and take your doctor's advice.
Is the use of Lipicure CV 10/75 Capsule safe during breastfeeding?
Lipicure CV may have very limited harmful effects for breastfeeding women.
What is the effect of Lipicure CV 10/75 Capsule on the Kidneys?
Lipicure CV may have mild side effects on the kidneys.
What is the effect of Lipicure CV 10/75 Capsule on the Liver?
Lipicure CV can have moderate side effects on the liver. If you notice any harmful effects then stop taking this drug right away. Consult your doctor before using this medicine again.
What is the effect of Lipicure CV 10/75 Capsule on the Heart?
Side effects of Lipicure CV rarely affect the heart.
If you are suffering from any of the following diseases, you should not take Lipicure CV 10/75 Capsule unless your doctor advises you to do so -
Is this Lipicure CV 10/75 Capsule habit forming or addictive?
No, there is no any evidence that Lipicure CV 10/75 Capsule is addictive.
Is it safe to drive or operate heavy machinery when consuming?
Lipicure CV 10/75 Capsule does not cause dizziness or sleep, so you can drive a vehicle or operate machinery also.
Is it safe?
Lipicure CV 10/75 Capsule should be used only after doctor's advice.
Is it able to treat mental disorders?
No, the use of Lipicure CV 10/75 Capsule in mental disorders is not effective.
Interaction between Food and Lipicure CV 10/75 Capsule
Some foods when eaten with Lipicure CV 10/75 Capsule can alter the onset of actions. Discuss this with your doctor.
Interaction between Alcohol and Lipicure CV 10/75 Capsule
Due to lack of research, there is no information about the side effects of taking Lipicure CV 10/75 Capsule with alcohol.
Lipicure CV comes in form of a tablet and ideally, it should be taken by mouth once daily as advised by your doctor. It can be taken with food or without food at any time of the day. Precautions must be taken in patients with liver disease, diabetes, and hypothyroidism.
No, Lipicure CV should not be discontinued without doctors advice. You are recommended to always consult a doctor before discontinuing this medicine.
Yes, Lipicure CV might cause hair loss but it occurs very rarely. This problem goes away after discontinuation of the drug. However, if you notice excessive hair loss then consult it with your doctor.
No, Lipicure CV does not cause diabetes. It has not been reported to cause diabetes. However, Lipicure CV might increase your blood sugar levels slightly. So, if you have diabetes keep a check on your blood sugar levels and in case of a sudden spike inform your doctor and take medicines accordingly.
Use Lipicure CV as advised by your doctor. Do not discontinue the drug suddenly or use it longer than prescribed by your doctor.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lipitor® (Atorvastatin Calcium)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 637-638
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 646-650
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Plavix (clopidogrel bisulfate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 630-631
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 335-336